317 related articles for article (PubMed ID: 11181641)
1. Increased atherosclerosis in myeloperoxidase-deficient mice.
Brennan ML; Anderson MM; Shih DM; Qu XD; Wang X; Mehta AC; Lim LL; Shi W; Hazen SL; Jacob JS; Crowley JR; Heinecke JW; Lusis AJ
J Clin Invest; 2001 Feb; 107(4):419-30. PubMed ID: 11181641
[TBL] [Abstract][Full Text] [Related]
2. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
Hazen SL; Heinecke JW
J Clin Invest; 1997 May; 99(9):2075-81. PubMed ID: 9151778
[TBL] [Abstract][Full Text] [Related]
3. Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice.
McMillen TS; Heinecke JW; LeBoeuf RC
Circulation; 2005 May; 111(21):2798-804. PubMed ID: 15911707
[TBL] [Abstract][Full Text] [Related]
4. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.
Bergt C; Pennathur S; Fu X; Byun J; O'Brien K; McDonald TO; Singh P; Anantharamaiah GM; Chait A; Brunzell J; Geary RL; Oram JF; Heinecke JW
Proc Natl Acad Sci U S A; 2004 Aug; 101(35):13032-7. PubMed ID: 15326314
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase-generated oxidants and atherosclerosis.
Podrez EA; Abu-Soud HM; Hazen SL
Free Radic Biol Med; 2000 Jun; 28(12):1717-25. PubMed ID: 10946213
[TBL] [Abstract][Full Text] [Related]
6. Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol.
Malle E; Wäg G; Thiery J; Sattler W; Gröne HJ
Biochem Biophys Res Commun; 2001 Dec; 289(4):894-900. PubMed ID: 11735131
[TBL] [Abstract][Full Text] [Related]
7. Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine.
Heinecke JW
Biofactors; 1997; 6(2):145-55. PubMed ID: 9259996
[TBL] [Abstract][Full Text] [Related]
8. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis.
Gaut JP; Yeh GC; Tran HD; Byun J; Henderson JP; Richter GM; Brennan ML; Lusis AJ; Belaaouaj A; Hotchkiss RS; Heinecke JW
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):11961-6. PubMed ID: 11593004
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosis.
Zeng L; Mathew AV; Byun J; Atkins KB; Brosius FC; Pennathur S
J Biol Chem; 2018 May; 293(19):7238-7249. PubMed ID: 29581235
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense.
Hirche TO; Gaut JP; Heinecke JW; Belaaouaj A
J Immunol; 2005 Feb; 174(3):1557-65. PubMed ID: 15661916
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.
Daugherty A; Dunn JL; Rateri DL; Heinecke JW
J Clin Invest; 1994 Jul; 94(1):437-44. PubMed ID: 8040285
[TBL] [Abstract][Full Text] [Related]
13. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase.
Aratani Y; Koyama H; Nyui S; Suzuki K; Kura F; Maeda N
Infect Immun; 1999 Apr; 67(4):1828-36. PubMed ID: 10085024
[TBL] [Abstract][Full Text] [Related]
14. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
[TBL] [Abstract][Full Text] [Related]
15. Relative contributions of myeloperoxidase and NADPH-oxidase to the early host defense against pulmonary infections with Candida albicans and Aspergillus fumigatus.
Aratani Y; Kura F; Watanabe H; Akagawa H; Takano Y; Suzuki K; Dinauer MC; Maeda N; Koyama H
Med Mycol; 2002 Dec; 40(6):557-63. PubMed ID: 12521119
[TBL] [Abstract][Full Text] [Related]
16. Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.
Choi DK; Pennathur S; Perier C; Tieu K; Teismann P; Wu DC; Jackson-Lewis V; Vila M; Vonsattel JP; Heinecke JW; Przedborski S
J Neurosci; 2005 Jul; 25(28):6594-600. PubMed ID: 16014720
[TBL] [Abstract][Full Text] [Related]
17. Chlorination and oxidation of the extracellular matrix protein laminin and basement membrane extracts by hypochlorous acid and myeloperoxidase.
Nybo T; Dieterich S; Gamon LF; Chuang CY; Hammer A; Hoefler G; Malle E; Rogowska-Wrzesinska A; Davies MJ
Redox Biol; 2019 Jan; 20():496-513. PubMed ID: 30476874
[TBL] [Abstract][Full Text] [Related]
18. [Role of myeloperoxidase in the host defense against fungal infection].
Aratani Y
Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):195-9. PubMed ID: 16940954
[TBL] [Abstract][Full Text] [Related]
19. Thiocyanate supplementation decreases atherosclerotic plaque in mice expressing human myeloperoxidase.
Morgan PE; Laura RP; Maki RA; Reynolds WF; Davies MJ
Free Radic Res; 2015 Jun; 49(6):743-9. PubMed ID: 25812586
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice.
Tiyerili V; Camara B; Becher MU; Schrickel JW; Lütjohann D; Mollenhauer M; Baldus S; Nickenig G; Andrié RP
Int J Cardiol; 2016 Feb; 204():29-36. PubMed ID: 26655530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
